Literature DB >> 22344932

AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation.

Maryline Drouet1, Cécile Vignal, Elisabeth Singer, Madjid Djouina, Luc Dubreuil, Antoine Cortot, Pierre Desreumaux, Christel Neut.   

Abstract

BACKGROUND: Inflammatory bowel diseases (IBD) patients are abnormally colonized by adherent-invasive Escherichia coli (AIEC). NOD2 gene mutations impair intracellular bacterial clearance. We evaluated the impact of antibiotic treatment on AIEC colonization in wildtype (WT) and NOD2 knockout mice (NOD2KO) and the consequences on intestinal inflammation.
METHODS: After 3 days of antibiotic treatment, mice were infected for 2 days with 10⁹ CFU AIEC and sacrificed 1, 5, and 60 days later. In parallel, mice were challenged with AIEC subsequent to a dextran sodium sulfate (DSS) treatment and sacrificed 9 days later. Ileum, colon, and mesenteric tissues were sampled for AIEC quantification and evaluation of inflammation.
RESULTS: Without antibiotic treatment, AIEC was not able to colonize WT and NOD2KO mice. Compared with nontreated animals, antibiotic treatment led to a significant increase in ileal and colonic colonization of AIEC in WT and/or NOD2KO mice. Persistent AIEC colonization was observed until day 5 only in NOD2KO mice, disappearing at day 60. Mesenteric translocation of AIEC was observed only in NOD2KO mice. No inflammation was observed in WT and NOD2KO mice treated with antibiotics and infected with AIEC. During DSS-induced colitis, colonization and persistence of AIEC was observed in the colon. Moreover, a dramatic increase in clinical, histological, and molecular parameters of colitis was observed in mice infected with AIEC but not with a commensal E. coli strain.
CONCLUSIONS: Antibiotic treatment was necessary for AIEC colonization of the gut and mesenteric tissues and persistence of AIEC was dependent on NOD2. AIEC exacerbated a preexisting DSS-induced colitis in WT mice.
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22344932     DOI: 10.1002/ibd.22908

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

1.  Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury.

Authors:  Sang-Uk Seo; Nobuhiko Kamada; Raúl Muñoz-Planillo; Yun-Gi Kim; Donghyun Kim; Yukiko Koizumi; Mizuho Hasegawa; Stephanie D Himpsl; Hilary P Browne; Trevor D Lawley; Harry L T Mobley; Naohiro Inohara; Gabriel Núñez
Journal:  Immunity       Date:  2015-04-07       Impact factor: 31.745

Review 2.  Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity.

Authors:  Margarita Martinez-Medina; Librado Jesus Garcia-Gil
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

3.  Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier.

Authors:  Valérie Gouyer; Laurent Dubuquoy; Catherine Robbe-Masselot; Christel Neut; Elisabeth Singer; Ségolène Plet; Karel Geboes; Pierre Desreumaux; Frédéric Gottrand; Jean-Luc Desseyn
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

Review 4.  Animal models of ulcerative colitis and their application in drug research.

Authors:  Daren Low; Deanna D Nguyen; Emiko Mizoguchi
Journal:  Drug Des Devel Ther       Date:  2013-11-12       Impact factor: 4.162

5.  Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis.

Authors:  Cherrie-Lee N Small; Sarah A Reid-Yu; Joseph B McPhee; Brian K Coombes
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 6.  Nod2: The intestinal gate keeper.

Authors:  Ziad Al Nabhani; Gilles Dietrich; Jean-Pierre Hugot; Frederick Barreau
Journal:  PLoS Pathog       Date:  2017-03-02       Impact factor: 6.823

7.  High carriage of adherent invasive E. coli in wildlife and healthy individuals.

Authors:  Oumaïra Rahmouni; Cécile Vignal; Marie Titécat; Benoît Foligné; Benjamin Pariente; Laurent Dubuquoy; Pierre Desreumaux; Christel Neut
Journal:  Gut Pathog       Date:  2018-06-14       Impact factor: 4.181

Review 8.  Why the discovery of adherent-invasive Escherichia coli molecular markers is so challenging?

Authors:  Carla Camprubí-Font; Margarita Martinez-Medina
Journal:  World J Biol Chem       Date:  2020-04-07

9.  Acute Infectious Gastroenteritis Potentiates a Crohn's Disease Pathobiont to Fuel Ongoing Inflammation in the Post-Infectious Period.

Authors:  Cherrie L Small; Lydia Xing; Joseph B McPhee; Hong T Law; Brian K Coombes
Journal:  PLoS Pathog       Date:  2016-10-06       Impact factor: 6.823

10.  Growth Control of Adherent-Invasive Escherichia coli (AIEC) by the Predator Bacteria Bdellovibrio bacteriovorus: A New Therapeutic Approach for Crohn's Disease Patients.

Authors:  Giulia Bonfiglio; Bruna Neroni; Giulia Radocchia; Arianna Pompilio; Francesco Mura; Maria Trancassini; Giovanni Di Bonaventura; Fabrizio Pantanella; Serena Schippa
Journal:  Microorganisms       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.